These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2955244)

  • 1. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS; Starr MS
    Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS; Starr MS
    Neuropharmacology; 1986 May; 25(5):455-63. PubMed ID: 3488514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS; Starr MS; Kilpatrick IC
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS; Starr MS
    Pharmacol Biochem Behav; 1986 Apr; 24(4):837-9. PubMed ID: 2940604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI; Fletcher GH; Starr MS
    Pharmacol Biochem Behav; 1987 Jan; 26(1):45-7. PubMed ID: 3494255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor depression: a new role for D1 receptors?
    Chandler CJ; Wohab W; Starr BS; Starr MS
    Neuroscience; 1990; 38(2):437-45. PubMed ID: 2148204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Feb; 20(2):589-97. PubMed ID: 2953990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(2):243-9. PubMed ID: 1355736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse.
    Abbott B; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1991 Feb; 38(2):259-63. PubMed ID: 1676166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of D1 and D2 dopamine receptors produces additive anorectic effects.
    Ladurelle N; Duterte-Boucher D; Costentin J
    Fundam Clin Pharmacol; 1991; 5(6):481-90. PubMed ID: 1683341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
    Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1984; 82(4):409-10. PubMed ID: 6427836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1985 Nov; 117(3):381-5. PubMed ID: 3878300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.